BE724745A - - Google Patents
Info
- Publication number
- BE724745A BE724745A BE724745DA BE724745A BE 724745 A BE724745 A BE 724745A BE 724745D A BE724745D A BE 724745DA BE 724745 A BE724745 A BE 724745A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT1090867A AT278835B (de) | 1967-12-01 | 1967-12-01 | Verfahren zur Herstellung von neuen 7,8-Dihydro-6H-thiopyrano[3,2-d]pyrimidin-5-oxyden und ihren Salzen |
Publications (1)
Publication Number | Publication Date |
---|---|
BE724745A true BE724745A (xx) | 1969-05-29 |
Family
ID=3625480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE724745D BE724745A (xx) | 1967-12-01 | 1968-11-29 |
Country Status (5)
Country | Link |
---|---|
AT (1) | AT278835B (xx) |
BE (1) | BE724745A (xx) |
ES (1) | ES360958A1 (xx) |
FR (2) | FR8437M (xx) |
NL (1) | NL6817160A (xx) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871739A (en) * | 1987-01-21 | 1989-10-03 | Merck & Co., Inc. | Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents |
US4889856A (en) * | 1987-08-31 | 1989-12-26 | Merck & Co., Inc. | 7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers |
US4978667A (en) * | 1986-12-15 | 1990-12-18 | Merck & Co., Inc. | Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents |
US4994464A (en) * | 1987-08-31 | 1991-02-19 | Merck & Co., Inc. | Piperazinylpyrimidines as β-adrenergic receptor blockers |
US5057517A (en) * | 1987-07-20 | 1991-10-15 | Merck & Co., Inc. | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0224722B1 (en) * | 1985-11-04 | 1993-01-07 | Merck & Co. Inc. | The use of 6H-7,8-Dihydrothiapyrano[3,2-d]pyrimidines for the manufacture of medicaments for use as hypoglycemic agents or as weight reducers for obese patients |
-
1967
- 1967-12-01 AT AT1090867A patent/AT278835B/de not_active IP Right Cessation
-
1968
- 1968-11-29 FR FR176054A patent/FR8437M/fr not_active Expired
- 1968-11-29 FR FR1593867D patent/FR1593867A/fr not_active Expired
- 1968-11-29 BE BE724745D patent/BE724745A/xx unknown
- 1968-11-29 NL NL6817160A patent/NL6817160A/xx unknown
- 1968-11-30 ES ES360958A patent/ES360958A1/es not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4978667A (en) * | 1986-12-15 | 1990-12-18 | Merck & Co., Inc. | Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents |
US4871739A (en) * | 1987-01-21 | 1989-10-03 | Merck & Co., Inc. | Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents |
US5057517A (en) * | 1987-07-20 | 1991-10-15 | Merck & Co., Inc. | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents |
US4889856A (en) * | 1987-08-31 | 1989-12-26 | Merck & Co., Inc. | 7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers |
US4994464A (en) * | 1987-08-31 | 1991-02-19 | Merck & Co., Inc. | Piperazinylpyrimidines as β-adrenergic receptor blockers |
Also Published As
Publication number | Publication date |
---|---|
ES360958A1 (es) | 1970-11-01 |
FR8437M (xx) | 1971-07-15 |
AT278835B (de) | 1970-02-10 |
NL6817160A (xx) | 1969-06-03 |
FR1593867A (xx) | 1970-06-01 |